1. Home
  2. NTRA vs MTD Comparison

NTRA vs MTD Comparison

Compare NTRA & MTD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Natera Inc.

NTRA

Natera Inc.

HOLD

Current Price

$244.06

Market Cap

27.0B

Sector

Health Care

ML Signal

HOLD

Logo Mettler-Toledo International Inc.

MTD

Mettler-Toledo International Inc.

HOLD

Current Price

$1,415.03

Market Cap

29.6B

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
NTRA
MTD
Founded
2003
1991
Country
United States
United States
Employees
N/A
N/A
Industry
Medical Specialities
Biotechnology: Laboratory Analytical Instruments
Sector
Health Care
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
27.0B
29.6B
IPO Year
2015
1997

Fundamental Metrics

Financial Performance
Metric
NTRA
MTD
Price
$244.06
$1,415.03
Analyst Decision
Strong Buy
Buy
Analyst Count
16
11
Target Price
$227.69
$1,418.64
AVG Volume (30 Days)
1.7M
146.1K
Earning Date
11-06-2025
11-06-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
8.22
EPS
N/A
40.11
Revenue
$2,116,676,000.00
$3,941,791,000.00
Revenue This Year
$32.77
$4.20
Revenue Next Year
$16.51
$4.86
P/E Ratio
N/A
$35.28
Revenue Growth
38.17
4.77
52 Week Low
$125.38
$946.69
52 Week High
$245.59
$1,525.17

Technical Indicators

Market Signals
Indicator
NTRA
MTD
Relative Strength Index (RSI) 80.03 47.12
Support Level $233.67 $1,393.37
Resistance Level $240.18 $1,525.17
Average True Range (ATR) 7.39 35.79
MACD 0.68 -7.23
Stochastic Oscillator 97.49 31.86

Price Performance

Historical Comparison
NTRA
MTD

About NTRA Natera Inc.

Natera Inc is a diagnostic and research company with proprietary molecular and bioinformatics technology. The company's key product offerings include its Panorama Non-Invasive Prenatal Test (NIPT) which screens for chromosomal abnormalities of a fetus as well as in twin pregnancies, typically with a blood draw from the mother, Horizon Carrier Screening (HCS) to determine carrier status for a large number of severe genetic diseases that could be passed on to the carrier's children, Signatera molecular residual disease (MRD) test, which detects circulating tumor DNA in patients previously diagnosed with cancer to assess molecular residual disease and monitor for recurrence; and Prospera, to assess organ transplant rejection.

About MTD Mettler-Toledo International Inc.

Mettler-Toledo supplies weighing and precision instruments to customers in the life sciences (around 55% of sales), industrial (around 40%), and food retail (around 5%) industries. Its products include laboratory and retail scales, pipettes, pH meters, thermal analysis equipment, titrators, metal detectors, and X-ray analyzers. Mettler leads the market for weighing instrumentation and controls more than 50% of the market for lab balances. The business is geographically diversified, with the Americas accounting for about 37% of sales, Europe about 28%, China about 16% and the rest of the world about 19%.

Share on Social Networks: